Yes I felt initially that article didn't engender much...

Yes I felt initially that article didn't engender much confidence that a listing in the US was the right way to go. However, on reflection it has to be remembered that Telix has a significant number of trials going and the development of these assets could reach a bottleneck where outside assistance is required to bring them to market. Telix is able to maintain between $100-130m cash in bank which is a healthy balance, but start progress on two Phase 3 trials for therapeutic assets for example and bills start to add up quickly.

Someone might correct me, but I believe it was mentioned somewhere that CB has hinted at partnering for prostate cancer therapy? I absolutely would not be surprised if Telix decided to go it alone for anything they do (they've done so well to date), but the impression I get is Berenbruch is aggressively pushing Telix to reach all markets for its assets as quickly as possible. I think to do that may require some help, possibly Stateside.